Bausch & Lomb Corp (BLCO): Cash & Equivalents
$383.00M
As of 2025-12-31
$367.00M
As of 2026-06-30
+2.7%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $383.00M | +25.6% | 2026-02-18, Balance as of period end |
| 2024-12-31 | $305.00M | -7.9% | 2026-02-18, Balance as of period end |
| 2023-12-31 | $331.00M | -6.5% | 2025-02-19, Balance as of period end |
| 2022-12-31 | $354.00M | +103.4% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $174.00M | n/a | 2023-02-22, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Bausch & Lomb Corp (BLCO) | 2025-12-31 | $383.00M | +25.6% |
| Cooper Companies, Inc. (COO) | 2025-10-31 | $110.60M | +2.8% |
| National Vision Holdings, Inc. (EYE) | 2026-01-03 | $38.71M | -47.7% |
| Warby Parker Inc. (WRBY) | 2025-12-31 | $286.36M | +12.7% |
| Staar Surgical Co (STAA) | 2026-01-02 | $153.15M | +6.2% |
| RxSight, Inc. (RXST) | 2025-12-31 | $19.95M | +19.4% |
| Innovative Eyewear Inc (LUCYW) | 2025-12-31 | $6.51M | +147.7% |
Compare BLCO, COO, EYE, WRBY side by side · Screen every company in Ophthalmic Goods ↗